MADRIGAL PHARMACEUTICALS, INC. (Nasdaq:MDGL)

Health Care/Life Sciences • Pharmaceuticals

CIK 1157601

Company

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.

Address
200 Barr Harbor Drive
Suite 200
West Conshohocken, Pennsylvania 19428

Employees
376

Stock Info

Close
$248.49

Day Range
238.93 - 249.43

52 Week Range
119.76 - 322.67

Average volume
461.33K

Short Interest
3.39M (02/15/24)

% of Float Shorted
20.95%

Market Cap
$4.91B

Revenue
N/A

Net Income
N/A

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$19.94

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

President, Chief Executive Officer & Director
William J Sibold MBA

Director, President-Research & Development
Rebecca A Taub MD

Director
Paul A Friedman MD

Director
Raymond Cheong MD, PhD

Independent Chairman
Julian Charles Baker

Lead Independent Director
Fred Bernard Craves PhD

Independent Director
Kenneth M Bate MBA

Independent Director
Richard S Levy MD

Independent Director
James M Daly MBA

SEC filings

Date	Form	Event
19 Aug, 2024	4
15 Aug, 2024	3
7 Aug, 2024	10-Q
7 Aug, 2024	8-K
27 Jun, 2024	4
27 Jun, 2024	8-K
27 Jun, 2024	4
27 Jun, 2024	4
27 Jun, 2024	4
27 Jun, 2024	4
27 Jun, 2024	4
18 Jun, 2024	4
14 Jun, 2024	144
14 Jun, 2024	144
14 Jun, 2024	4
13 Jun, 2024	4
13 Jun, 2024	144
12 Jun, 2024	144
11 Jun, 2024	144
6 Jun, 2024	144
23 May, 2024	4
16 May, 2024	4
14 May, 2024	144
7 May, 2024	S-3ASR
7 May, 2024	10-Q
7 May, 2024	424B3
7 May, 2024	8-K
7 May, 2024	424B5
7 May, 2024	8-K
29 Apr, 2024	DEFA14A
29 Apr, 2024	DEF 14A
29 Apr, 2024	ARS
10 Apr, 2024	4
10 Apr, 2024	4
5 Apr, 2024	4
5 Apr, 2024	4
3 Apr, 2024	144
3 Apr, 2024	4
3 Apr, 2024	4
3 Apr, 2024	4
3 Apr, 2024	144
2 Apr, 2024	8-K
1 Apr, 2024	144
1 Apr, 2024	144
1 Apr, 2024	144
25 Mar, 2024	SC 13D/A
25 Mar, 2024	4
21 Mar, 2024	3
20 Mar, 2024	8-K
20 Mar, 2024	424B5
18 Mar, 2024	424B5
15 Mar, 2024	8-K
28 Feb, 2024	8-K
28 Feb, 2024	8-K
28 Feb, 2024	10-K
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
13 Feb, 2024	SC 13G/A
13 Feb, 2024	SC 13G/A
29 Jan, 2024	SC 13G/A
25 Jan, 2024	4
25 Jan, 2024	4
25 Jan, 2024	4
25 Jan, 2024	4
25 Jan, 2024	4
25 Jan, 2024	4
25 Jan, 2024	UPLOAD
22 Jan, 2024	SC 13G/A
18 Jan, 2024	4
18 Jan, 2024	4
18 Jan, 2024	4
18 Jan, 2024	4
18 Jan, 2024	4
17 Jan, 2024	CORRESP
8 Jan, 2024	8-K
3 Jan, 2024	UPLOAD
18 Dec, 2023	4
14 Dec, 2023	4
14 Dec, 2023	4
14 Dec, 2023	4
14 Dec, 2023	CORRESP
13 Dec, 2023	SC 13D/A
11 Dec, 2023	4
8 Dec, 2023	CORRESP
6 Dec, 2023	4
1 Dec, 2023	4
22 Nov, 2023	3
22 Nov, 2023	4
21 Nov, 2023	UPLOAD
21 Nov, 2023	SC 13D/A
21 Nov, 2023	4
21 Nov, 2023	4
15 Nov, 2023	4
15 Nov, 2023	4
13 Nov, 2023	SC 13G
6 Nov, 2023	8-K
6 Nov, 2023	10-Q
10 Oct, 2023	SC 13G/A
5 Oct, 2023	SC 13D/A
5 Oct, 2023	4
2 Oct, 2023	8-K
2 Oct, 2023	424B5
28 Sep, 2023	424B5
25 Sep, 2023	8-K
14 Sep, 2023	8-K
13 Sep, 2023	3
13 Sep, 2023	8-K	CEO Change
13 Sep, 2023	8-K
13 Sep, 2023	4
11 Sep, 2023	S-8
8 Sep, 2023	SC 13G
8 Aug, 2023	8-K
8 Aug, 2023	10-Q
8 Aug, 2023	SC 13D/A
8 Aug, 2023	424B3
17 Jul, 2023	8-K
12 Jul, 2023	144
30 Jun, 2023	8-K
26 Jun, 2023	144
26 Jun, 2023	144
9 May, 2023	424B5
9 May, 2023	8-K
9 May, 2023	8-K
9 May, 2023	10-Q
1 May, 2023	DEFA14A
1 May, 2023	DEF 14A
21 Apr, 2023	PRE 14A
3 Mar, 2023	10-K/A
2 Mar, 2023	4
23 Feb, 2023	10-K
23 Feb, 2023	8-K
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
9 Feb, 2023	8-K
9 Feb, 2023	SC 13G/A
6 Feb, 2023	SC 13G/A
2 Feb, 2023	SC 13G
1 Feb, 2023	SC 13G/A
19 Jan, 2023	4
18 Jan, 2023	4
18 Jan, 2023	4
18 Jan, 2023	4
18 Jan, 2023	4
18 Jan, 2023	4
18 Jan, 2023	4
10 Jan, 2023	8-K
6 Jan, 2023	4
28 Dec, 2022	4
28 Dec, 2022	4
23 Dec, 2022	424B5
23 Dec, 2022	8-K
19 Dec, 2022	8-K
3 Nov, 2022	10-Q
3 Nov, 2022	8-K
12 Aug, 2022	4
4 Aug, 2022	8-K
4 Aug, 2022	10-Q
21 Jun, 2022	4
21 Jun, 2022	4
21 Jun, 2022	4
21 Jun, 2022	4
21 Jun, 2022	4
21 Jun, 2022	4
17 Jun, 2022	8-K
19 May, 2022	SC 13G
9 May, 2022	8-K
9 May, 2022	8-K
9 May, 2022	10-Q
2 May, 2022	DEFA14A
2 May, 2022	DEF 14A
24 Feb, 2022	4
24 Feb, 2022	8-K
24 Feb, 2022	4
24 Feb, 2022	4
24 Feb, 2022	4
24 Feb, 2022	10-K
24 Feb, 2022	4
24 Feb, 2022	4
15 Feb, 2022	SC 13G
14 Feb, 2022	SC 13G/A
11 Feb, 2022	SC 13G/A
10 Feb, 2022	SC 13G/A
4 Feb, 2022	SC 13G/A
3 Feb, 2022	SC 13G/A
2 Feb, 2022	5
7 Dec, 2021	4
7 Dec, 2021	SC 13D/A
7 Dec, 2021	4
4 Nov, 2021	10-Q
4 Nov, 2021	8-K
3 Nov, 2021	4
5 Aug, 2021	10-Q
5 Aug, 2021	8-K
4 Aug, 2021	4
4 Aug, 2021	3
9 Jul, 2021	SC 13G/A
29 Jun, 2021	S-8
21 Jun, 2021	8-K
21 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	4
21 Jun, 2021	4
1 Jun, 2021	S-3ASR
1 Jun, 2021	8-K
1 Jun, 2021	424B5
19 May, 2021	3
19 May, 2021	4
18 May, 2021	8-K
6 May, 2021	10-Q
6 May, 2021	8-K
30 Apr, 2021	DEFA14A
30 Apr, 2021	DEF 14A
25 Feb, 2021	10-K
25 Feb, 2021	8-K
23 Feb, 2021	4
23 Feb, 2021	4
23 Feb, 2021	4
23 Feb, 2021	4
23 Feb, 2021	4
16 Feb, 2021	SC 13G/A
16 Feb, 2021	SC 13G/A
12 Feb, 2021	SC 13G
12 Feb, 2021	SC 13G/A
11 Feb, 2021	5
10 Feb, 2021	SC 13G/A
4 Feb, 2021	SC 13G/A
2 Feb, 2021	SC 13G

Last update:2024-03-06 12:18:00.708128

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.